Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| January 7th, 2028 |
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| February 4th, 2025 |
USAID SUstaining Control of the HIV Epidemic through quality Services, resilient Systems, and Community Outreach (SUCESSO) _ Sofala & Niassa |
Mozambique USAID-Maputo |
| February 17th, 2025 |
PEPFAR Community Led Monitoring (CLM)-Zambia |
U.S. Mission to Zambia |
| March 12th, 2025 |
Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R34 Clinical Trials Required) |
National Institutes of Health |
| March 12th, 2025 |
Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01 Clinical Trials Required) |
National Institutes of Health |
| November 13th, 2026 |
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) |
National Institutes of Health |
| November 13th, 2026 |
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) |
National Institutes of Health |
| November 13th, 2026 |
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) |
National Institutes of Health |
| January 7th, 2028 |
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 16th, 2027 |
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) |
National Institutes of Health |
| November 16th, 2027 |
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) |
National Institutes of Health |
| March 7th, 2025 |
In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed |
National Institutes of Health |
| November 12th, 2027 |
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) |
National Institutes of Health |
| November 12th, 2027 |
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 12th, 2027 |
NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Clinical Trial Required) |
National Institutes of Health |
| January 7th, 2028 |
NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required) |
National Institutes of Health |
| December 1st, 2025 |
Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trials Not Allowed) |
National Institutes of Health |
| February 13th, 2025 |
Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
|
| January 6th, 2028 |
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
| January 7th, 2028 |
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 7th, 2026 |
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) |
National Institutes of Health |
| September 7th, 2026 |
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) |
National Institutes of Health |
| September 7th, 2026 |
Alcohol Health Services Research (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2026 |
Alcohol Health Services Research (R34 Clinical Trial Optional) |
National Institutes of Health |
| October 15th, 2027 |
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required) |
National Institutes of Health |
| October 15th, 2027 |
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) |
National Institutes of Health |
| October 15th, 2027 |
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) |
National Institutes of Health |
| October 15th, 2027 |
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) |
National Institutes of Health |
| October 15th, 2027 |
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) |
National Institutes of Health |
| October 15th, 2027 |
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required) |
National Institutes of Health |
| October 15th, 2027 |
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) |
National Institutes of Health |
| October 15th, 2027 |
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required) |
National Institutes of Health |
| October 15th, 2027 |
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required) |
National Institutes of Health |
| April 30th, 2025 |
Promoting Economic Prosperity and Human Development - Malabo Public Diplomacy Small Grants |
U.S. Mission to Equatorial Guinea |
| May 7th, 2026 |
HIV Prevention and Alcohol (R01 Clinical Trials Optional) |
National Institutes of Health |
| May 7th, 2026 |
HIV Prevention and Alcohol (R34 Clinical Trials Optional) |
National Institutes of Health |
| January 7th, 2026 |
Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2028 |
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required) |
National Institutes of Health |
